Gynecologic Pathology I Pathology of the Cervix, Vagina, and Vulva



Similar documents
worry When to Cervical Abnormalities CME Workshop What s the situation? What are the trends? By Dianne Miller, MD, FRCSC In this article:

Explanation of your PAP smear

Cancer of the Cervix

Cervical Cancer The Importance of Cervical Screening and Vaccination

PROPERTY OF ELSEVIER SAMPLE CONTENT - NOT FINAL ABNORMAL PAP SMEAR (ABNORMAL CERVICAL CYTOLOGIC FINDINGS) Kathleen Dor

Cervical Cancer Prevention and Early Detection What is cervical cancer?

Cervical Cancer Screening and Management Guidelines: Changing Again, Huh?

Pap smears, cytology and CCHC lab work and follow up

NATIONAL GUIDELINE FOR CERVICAL CANCER SCREENING PROGRAMME

Management of Abnormal Pap Smear Clinical Practice Guideline

Carcinoma of the vagina is a relatively uncommon disease, affecting only about 2,000 women in

Human Papilloma Virus (HPV)

2015 RN.ORG, S.A., RN.ORG, LLC

Cervical Cancer Screening Guideline

The society for lower genital tract disorders since 1964.

HUMAN PAPILLOMAVIRUS (HPV) FACT SHEET

Understanding. Cervical Changes A Health Guide for Women. National Cancer Institute U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

Basic Professional Training Program for Associate Medical Technologist

Cervical Screening and HPV Vaccine Guidelines In Saudi Arabia. Prof. Mohammed Addar Chairmen Gyneoncology section KKUH, King Saud University

Screening for Cancer of the Cervix

What is HPV? Low-risk HPV types. High-risk HPV types

GLOBAL CONCERNS ABOUT HPV VACCINES FACT SHEET

Cervical Cancer. Cervical smear test. The cervix. Dysplasia. Cervical cancer. The female reproductive system

SCREENING FOR CANCER OF THE CERVIX

Invasive Cervical Cancer. Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology

Chapter 14 Cancer of the Cervix Uteri

Examples of good screening tests include: mammography for breast cancer screening and Pap smears for cervical cancer screening.

American Academy of Family Physicians

Cervical Cancer. What is cancer?

Disorders of the Vulva

The Cervical Screening Manual

Vulval Intraepithelial Neoplasia (VIN)

PathoBasic - Vulva, Vagina, Cervix. E.Obermann

Accent on Health Obgyn, PC HPV Frequently Asked Questions

Cervical Cancer Screening. Clinical Practice Guidelines for Average Risk Women

ALABAMA BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM PROVIDER MANUAL

Glossary. amenorrhea, primary - from the beginning and lifelong; menstruation never begins at puberty.

Making Sense of Your Pap and HPV Test Results

Cervical cancer screening with the HPV test and the Pap test in women ages 30 and older

Medicaid Family Planning Waiver Services CPT Codes and ICD-9 Diagnosis Codes

Biomedical Engineering for Global Health. Lecture Thirteen

HPV, Cervical Dysplasia and Cancer

An abnormal Pap smear - what does it mean?

Chapter 3. Testing and reporting the results of visual inspection with Lugol's iodine (VILI)

Nicole Kounalakis, MD

Frequently Asked Questions About Ovarian Cancer

The Pap Smear: Guidelines for Screening and Follow-up

Cervical cancer is the second most common cancer among South African women

Medicaid Family Planning Waiver Services CPT Codes and ICD-10 Diagnosis Codes

Sage Screening Program. Provider Manual

Preventive Care Guideline for Asymptomatic Low Risk Adults Age 18 through 64

CERVICAL CANCER What every woman should know What is a cervix?

Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause.

How To Treat A Uterine Sarcoma

COMPARATIVE STUDY OF CYTOLOGIC AND COLPOSCOPIC FINDINGS IN PRECLINICAL CERVICAL CANCER Penagaluru Radha 1, Yaragani Padma 2, Mrudula Priyanka 3

Introduction Ovarian cysts are a very common female condition. An ovarian cyst is a fluid-filled sac on an ovary in the female reproductive system.

WOOD COUNTY SCHOOL OF PRACTICAL NURSING. Medical/Surgical Nursing: Reproductive

Colposcopy. Information for patients. Women s & Children s

The link between cervical cancer and HPV (human papillomavirus)

Ductal carcinoma in situ (DCIS)

CARDCARE PROTECTOR CERTIFICATE OF INSURANCE

Guidelines for reporting histopathology of cervical carcinoma

Introduction to Gynecologic Oncology

Leader's Resource. Note: Both men and women can have an STD without physical symptoms.

GUIDELINE DOCUMENT CERVICAL CANCER SCREENING IN SOUTH AFRICA 2015

2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors

Protocol for an integrated data request of test results from the laboratories of pathological anatomy. SNOMED 3.5VF - users version January 2016

Metastatic Cervical Cancer s/p Radiation Therapy, Radical Hysterectomy and Attempted Modified Internal Hemipelvectomy

This module consists of four units which will provide the user a basic knowledge of cancer as a disease.

Breast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D.

R-16: Chronic nonspecific cervisit

Gynecology Abnormal Pelvic Anatomy and Physiology: Cervix. Cervix. Nabothian cysts. cervical polyps. leiomyomas. Cervical stenosis

Policy Wording. Together, all the way.

Immunization Healthcare Branch. Human Papillomavirus Vaccination Program Questions and Answers. Prepared by

Specimen collection and transport for Chlamydia trachomatis and Neisseria gonorrhoeae testing

Introduction to Pathology and Diagnostic Medicine

Cervical Cancer Screening

Genital Human Papillomavirus. Patti E. Gravitt, PhD Johns Hopkins University

INFLAMMATION AND REACTIVE CHANGES IN CERVICAL EPITHELIUM

The Diagnosis of Cancer in the Pathology Laboratory

FRIEND TO FRIEND CPT CODES Diagnostic digital breast tomosynthesis, unilateral (list separately in addition to code for primary procedure)

HPV OncoTect E6, E7 mrna Kit A highly specific molecular test for early detection of cervical cancer

Screening for Cancer in Light of New Guidelines and Controversies. Christopher Celio, MD St. Jude Heritage Medical Group

Guidelines for Preventative Health Care in LGBT Populations

HPV and HPV Testing. Human Papilloma Virus (HPV) What are viruses? What is HPV?

Cancer Facts for Women

Get the Facts About Gynecologic Cancer

Accent on Health Obgyn, PC HERPES Frequently Asked Questions

OBJECTIVES By the end of this segment, the community participant will be able to:

Cervical Dysplasia and HPV.

Preventing Cervical Cancer with Gardasil Jana Ogden RN, MSN, MBA-HCA, IHCC Nursing Faculty. Upon Completion of the Lesson the student will be able to:

NHS Cervical Screening Having a colposcopy

Breast Imaging Made Brief and Simple. Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA

Transcription:

Carey Z. August, M.D. Gynecologic Pathology I UIC College of Medicine Attending Pathologist, Advocate Illinois Masonic Medical M2 Pathology Course Center Lecture #53 Clinical Assistant Professor of Pathology, UIC Monday, January 26, 2004 Phone: 773-296-7900 8:30-9:20 e-mail: carey.august-md@advocatehealth.com Reading: Robbins Pathologic Basis of Disease, 6 th edition, 1999, pp.1036-1053 Summary: This lecture will present infectious, inflammatory, preneoplastic, and neoplastic diseases of the lower female genital tract. Important concepts will include the significance of HPV in dysplasia and carcinogenesis and the role of the Pap smear in detection and prevention of dysplasia and cancer. Keywords: Cervix, vulva, vagina, HPV, Pap smear, dysplasia, squamous cell carcinoma, clear cell carcinoma. Goals and objectives: The student should know the information contained in the reading and the hand-out. In particular: 1. Explain the anatomy of the transformation zone, how it changes during a female s lifetime, and its significance in cervical disease. 2.Relate the evidence linking HPV to dysplasia and carcinogenesis. 3.Describe the morphology and clinical significance of varying degrees of dysplasia. 4.Know the natural history and staging of cervical cancer. 5.Explain the epidemiology of vaginal clear cell carcinoma. - 1 -

CERVIX I.A brief but necessary review of anatomy and histology A.Two parts of the cervix: portio vaginalis (stratified squamous epithelium) and endocervix (mucus-secreting glandular epithelium) which meet at the squamocolumnar junction (SCJ) B.Changes in the position of the SCJ: 1.At birth, SCJ is at cervical os 2.In child-bearing years, endocervix is everted. a.exposed columnar epithelium=ectropion; implications for STD s. b.squamous metaplasia of this ectropion leads to TRANSFORMATION ZONE, which is the site of development of most precancerous and cancerous conditions of the cervix. c.transformation zone location changes during reproductive years and migrates cephalad at menopause. II.Cervicitis, Nabothian cysts, polyps A.Normal cervicovaginal flora=doderlein bacilli B.Nonspecific cervicitis is common; associated with a variety of bacteria. C.Specific pathogens: Herpes Simplex (ulceration, multinucleated giant cells), Chlamydia trachomatis (follicular cervicitis), Trichomonas vaginalis (may induce cellular changes suggesting dysplasia-see below), gonococci, mycoplamsa. D.Nabothian cysts-mucous cysts which may be visible to the naked eye; reflect chronic inflammation; squamous metaplasia obliterates crypt opening of endocervical mucosa. E.Endocervical polyps-reflection of chronic cervicitis; may cause spotting or bleeding; NOT neoplastic. III.Cervical Intraepithelial Neoplasia CIN (Dysplasia) A.Precursors of squamous cell carcinoma of the cervix of varying degrees, manifested morphologically by varying degrees of cytologic atypia, yet ALWAYS INTRAEPITHELIAL (confined by basement membrane-do not infiltrate stroma). 1.Classified by degree of morphologic abnormality: a. CIN I-Mild dysplasia-undifferentiated, vertically-oriented cells occupy up to onethird of thickness of epithelium and mildly atypical cells are present on the surface. Changes may regress and are unlikely to progress to cancer. b. CIN II-Moderate dysplasia-undifferentiated, vertically-oriented cells occupy up to two-thirds of thickness of epithelium and moderately atypical cells are present on the surface. Less likely to regress and more likely to progress to cancer than mild dysplasia. c. CIN III-Severe dysplasia/carcinoma in situ-undifferentiated, vertically-oriented cells in full thickness of epithelium and severely atypical cells are present on the surface. - 2 -

2.The Papanicolaou Smear-a success story in cancer screening a. Since most cervical cancers are preceded by CIN, regular Pap smears allow for detection of precancerous changes. Pap smear can also detect cancers of cervix and other genital organs. b. Morphologic evaluation of the cytologic changes in the most superficial cell layers of the endocervix, ectocervix, and vagina. c. Adequate sampling, good preparation, and careful evaluation are all key features. d. Bethesda System-most current classification of Pap smears. e. Pap smear is a screening technique with false positives and false negatives. Pap smear diagnoses are confirmed by colposcopy and biopsy. 3.HPV (Human Papilloma Virus)-the most important (although not only) factor in cervical carcinogenesis. a. Risk factors for cervical cancer implicate a sexually transmitted agent (such as HPV): early age at first intercourse; multiple sexual partners; male partner with multiple previous sexual partners. Co-carcinogens include immune status, cigarette smoking. b. Causative agent of condyloma accuminatum (seen on external genitalia). c. Detected by in situ hybridization in 85% of cervical cancers and 90% of CIN. d. Low-risk HPV: 6,11,42,44-associated with condyloma and low grade CIN; exists in their squamous cells in free (episomal) form. e. High-risk HPV: 16,18,31,33-associated with high grade CIN and cancer; exists in their squamous cells integrated (covalently linked) into host DNA. f. High-risk HPV can transform cells in culture because their E6 and E7 viral oncogenes have the ability to do this; the E6 and E7 of low-risk HPV have different sequences and cannot transform cells in culture. g. High -risk E6 binds to tumor-suppressor gene p53 and accelerates is degradation. h. High -risk E7 binds to RB gene and displaces transcription factors normally sequestered by RB. i. Some high-risk HPV (HPV 16) are associated with chromosomal abnormalities. IV.Carcinoma-The vast majority (>75%) of carcinomas of the cervix are squamous cell carcinoma, but other forms, including adenocarcinoma and small cell carcinoma (which may be associated with HPV 18) occur as well. A.Peak age incidence: 40-45 years. Symptoms: abnormal Pap, bleeding (especially post-coital), leukorrhea, dyspareunia. B.Gross morphology: Fungating, ulcerating, infiltrative C.Microscopic morphology of squamous cell carcinoma: can be keratinizing or nonkeratinizing. D.Spreads locally, as reflected in staging system: I.Confined to cervix II.Beyond cervix but not onto the pelvic wall or to the lower third of the vagina. - 3 -

III.To the pelvic wall or to lower third of the vagina. IV.Beyond the true pelvis (distant metastasis, mucosa of bladder or rectum). VAGINA I.Vaginal intraepithelial neoplasia (VAIN) and Squamous cell carcinoma A.Much less common than cervical intraepithelial neoplasia and carcinoma. B.Generally associated with HPV C.Frequent association with cervical and/or vulvar HPV, intraepithelial neoplasia, and cancer. II.Clear cell adenocarcinoma-association of many (but not all) with DES in utero. A.Daughters of women given DES in pregnancy may have vaginal adenosis (considered a precursor lesion)-glandular epithelium in the vagina. B.A small percentage of these patients develop clear cell adenocarcinoma of the vagina. III.Embryonal rhabdomyosarcoma A.Pediatric malignancy (sarcoma arising from primitive skeletal muscle). B.Called sarcoma botryoides because of gross morphology: grape-like clusters projecting out of vagina. C.Characteristic cell is the rhabdomyoblast with striations. D.Conservative surgery and chemotherapy. VULVA I. Vulvar dystrophies A.Lichen sclerosus-(aka lichen sclerosus et atrophicus )generally (but not always) postmenopausal 1.Vulvar skin appears parchment-like ; epidermis may be atrophic; dermal collagen hyalinized; chronic inflammation. 2.May be associated with autoimmune disorders. 3.Patients RARELY develop squamous cell carcinoma NOT considered a premalignant lesion. B.Squamous hyperplasia (aka hyperplastic dystrophy ) II.Condyloma accuminatum-cauliflower-like growths, generally HPV 6 or 11 III.Vulvar intraepithelial neoplasia (VIN) and squamous cell carcinoma A.VIN I, II, III representing mild, moderate, and severe dysplasia/cis, respectively. Most cases of VIN are VIN III. - 4 -

B.Two types of VIN III- 1. Classic ( Bowenoid )- younger patients (<45), associated with HPV, may be multicentric, may regress, less likely to progress to invasive carcinoma than the simplex type. 2. Simplex -older patients, less likely associated with HPV, more likely to progress to or be associated with invasive cancer. C.Invasive squamous cell carcinoma 1.Generally exophytic lesions. 2.Risk of metastasis related to size, depth of invasion, lymphatic invasion. IV.Extramammary Paget s disease A.Intraepithelial adenocarcinoma cells (contain mucin) localized within the squamous epithelium. B.Origin of cells unknown; perhaps primitive epithelial progenitor cells. C.Different from Paget s disease of the nipple since, unlike the mammary Paget s, extramammary Paget s is very infrequently associated with an invasive carcinoma of the vulva. D.Forms a red, maplike area. Infiltrates microscopically beyond its gross borders, so difficult to excise completely; likely to recur. E.May be associated with a malignancy of breast, bladder, or GI tract. V.Miscellaneous A.Vulvovaginal melanoma-rare but bad prognosis because often detected late. B.Bartholin cyst-benign cyst from inflammation of Bartholin s gland. - 5 -